(Q90591389)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

title

Insights from nanomedicine into chloroquine efficacy against COVID-19 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

1 reference

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

author name string

Matthew Frieman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Joy Wolfram

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

publication date

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

published in

Nature Nanotechnology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

page(s)

247-249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

27 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

A Novel Coronavirus from Patients with Pneumonia in China, 2019

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Antimalarials - are they effective and safe in rheumatic diseases?

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Effects of chloroquine on viral infections: an old drug against today's diseases?

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Chloroquine and nanoparticle drug delivery: A promising combination

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Clinical cancer nanomedicine

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Liposomal chemotherapeutics

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

A systematic screen of FDA-approved drugs for inhibitors of biological threat agents

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.

1 reference

https://api.crossref.org/works/10.1038%2FS41565-020-0674-9

7 January 2021

10.1038/S41565-020-0674-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 May 2020

COVIDWHO ID

covidwho-14317

0 references

1125821294

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32203437%20AND%20SRC:MED&resulttype=core&format=json